The Ibogaine standard is a tool that we use to help educate you, as a consumer, about safe Ibogaine treatment practices.
It is also used to help you avoid unsafe or unethical Ibogaine providers. Background Since the Ibogaine treatment that we provide is not regulated by the FDA, anyone with access to the drug can dub themselves an Ibogaine provider. These “providers” have no medical licensing, very little in the way of staff, and no way to deal with any medical emergencies that may arise. Because of this fact, and the fact that many people are easily convinced to visit these so-called providers, many individuals have suffered a variety of complications and experienced physical and/or mental harm. This is why the Ibogaine Standard was created. Its goal is to help maintain the integrity of the Ibogaine community while helping the consumer find the safest and most reliable Ibogaine provider available.
The primary objective of the Ibogaine standard is to improve the quality of Ibogaine treatments by providing potential patients with up-to-date information about safe and reliable Ibogaine treatment providers and procedures. As Ibogaine treatments are only safe as long as proper procedures are followed, this online resource helps to educate guests as to the best questions to ask a treatment facility before committing to a treatment plan.
Our clinic, run by Executive Director David Dardashti, is an addiction research facility located near Playa Del Carmen, Mexico. Our director and his team of licensed Ibogaine professionals are working toward creating the safest and most efficient way to treat addiction and destructive tendencies with Ibogaine. The safety and well being of the patients is the primary goal of all members of our team.
Physical and psychological screening is required prior to a person being considered for participation in the Ibogaine treatment program. Patients are subjected to a blood test to check for liver abnormalities, and an EKG to check heart function. Any problems with the liver, heart, or lungs will generally result in exclusion from treatment. Long-term addicts, who suffer from additional health problems, and people who are suffering from extreme mental illness, may also be excluded, to ensure the safety of the patients and the staff. Once these assessments have been completed – and provided the patient is well enough to begin – the protocol will be administered.
Traditional Ibogaine Dosage Protocol Once the patient has completed the assessments, bodyweight should be measured. Once this measurement has been taken, the proper dosage of Ibogaine can be calculated. Ibogaine HCl is administered in doses of 10 milligrams per kilo (mg/k) for male patients and 9 mg/k for female patients. Two forms of the drug are currently available on the European market; pure Ibogaine HCl, which is the variant that we use, and “Indra iboga extract” which is usually packaged at ¼ the strength of the pure HCl. This requires a much higher dose, and is known to frequently induce vomiting. Patients who are addicted to opiates, such as heroin and methadone, require a much higher dose of Ibogaine. Typically, the dosage is doubled, making the proper measurement of 20 mg/k for male patients and 18 mg/k for female patients. This is the direct result of the opiates’ effect on the chemical receptors in the brain – effects which are known to block the desired results of Ibogaine. Most professionals recommend that Ibogaine only be delivered in a single dose. If more than one dose is required, patients should wait at least one month between doses, since the drug and its metabolites linger within the body.